Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

541
Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
541

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Incremental Prognostic Value of Cardiac Magnetic Resonance Beyond Biomarker Staging in Transthyretin Cardiac Amyloidosis.

European heart journal. Cardiovascular Imaging·2026
Same author

Authors' reply to Outcomes of Lynch syndrome endometrial surveillance in the Netherlands.

EClinicalMedicine·2026
Same author

Predictors of Long-Term Outcomes in Hypertrophic Cardiomyopathy: The NHLBI HCM Registry.

JAMA·2026
Same author

Deep secretome analysis reveals the effects of LiCl on fibroangiogenic remodeling in coculture and mouse models of peritoneal dialysis.

Science signaling·2026
Same author

Local Immunometabolic Intervention With Alanyl-Glutamine Resolves Peritoneal Dialysis-Induced Immune Cell Dysfunction.

Kidney international reports·2026
Same author

Redefining Right Ventricular Function: Incremental Prognostic Utility of Effective RVEF on CMR in Functional Tricuspid Regurgitation-A Multicenter Validation Study.

JACC. Cardiovascular imaging·2026

相关实验视频

Updated: May 2, 2026

In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
08:13

In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography

Published on: February 16, 2016

21.6K

慢性心脏病发作大小测量的可复制性通过对比增强的磁共振成像.

Heiko Mahrholdt1, Anja Wagner, Thomas A Holly

  • 1Northwestern University Medical School Feinberg Cardiovascular Research Institute, Chicago, Ill, USA.

Circulation
|October 31, 2002
PubMed
概括

与对比度增强的MRI在患有心肌梗塞的患者中提供可重现的心脏病发作大小测量. 它的临床可复制性与SPECT成像相比较好.

更多相关视频

Histological Quantification of Chronic Myocardial Infarct in Rats
09:45

Histological Quantification of Chronic Myocardial Infarct in Rats

Published on: December 11, 2016

14.7K
Middle Cerebral Artery Occlusion Allowing Reperfusion via Common Carotid Artery Repair in Mice
06:59

Middle Cerebral Artery Occlusion Allowing Reperfusion via Common Carotid Artery Repair in Mice

Published on: January 23, 2019

18.8K

相关实验视频

Last Updated: May 2, 2026

In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
08:13

In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography

Published on: February 16, 2016

21.6K
Histological Quantification of Chronic Myocardial Infarct in Rats
09:45

Histological Quantification of Chronic Myocardial Infarct in Rats

Published on: December 11, 2016

14.7K
Middle Cerebral Artery Occlusion Allowing Reperfusion via Common Carotid Artery Repair in Mice
06:59

Middle Cerebral Artery Occlusion Allowing Reperfusion via Common Carotid Artery Repair in Mice

Published on: January 23, 2019

18.8K

科学领域:

  • 心血管成像 - 心血管成像
  • 放射学 放射学是一门学科.
  • 核医学是一种核医学.

背景情况:

  • 对比度增强的MRI用于心脏病发作大小的可复制性尚未得到充分证实.
  • 需要与技术-99m-sestamibi (MIBI) 单光子发射计算断层扫描 (SPECT) 进行比较.

研究的目的:

  • 为了比较对比增强MRI与MIBI SPECT的可重现性,以确定慢性心肌梗塞患者的心脏病发作的大小.

主要方法:

  • 20名患者接受了两次MRI扫描 (一个带有对比,一个没有) 和15名患者在同一天接受了两次SPECT扫描.
  • 心脏病发作的大小被量化为左心室质量的百分比 (%LV).
  • 在对比后的10分钟和27分钟进行了MRI扫描.

主要成果:

  • 平均心脏病发作大小是MRI和SPECT的14%LV.
  • 核磁共振显示可重复系数为+/-2.4%LV,而SPECT具有+/-4.0%LV.
  • 在重复的MRI扫描,重复的SPECT扫描之间,或在MRI和SPECT之间,没有发现心脏病发作大小的系统差异.

结论:

  • 与对比度增强的MRI在对比度后10到30分钟之间提供稳定的心脏病发作大小测量.
  • 与常规的SPECT相比,对比度增强的MRI用于心脏病发作大小的临床可重现性是有利的.